A Case of Hepatocellular Carcinoma Successfully Resumed Atezolizumab and Bevacizumab After Associated Grade 3 Diarrhea and Grade 2 Colitis: Case Report and Literature Review

Systemic chemotherapy has shown a significant survival benefit in patients with hepatocellular carcinoma (HCC). However, it is associated with various immune-related adverse events (irAEs). We report a case with grade 3 diarrhea and grade 2 colitis following systemic chemotherapy, successfully treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuji, Takahiro, Arai, Jun, Otoyama, Yumi, Nio, Yuta, Sugiura, Ikuya, Nakajima, Yoko, Kajiwara, Atsushi, Ichikawa, Yuki, Uozumi, Shojiro, Shimozuma, Yuu, Uchikoshi, Manabu, Sakaki, Masashi, Nozawa, Hisako, Momo, Kenji, Sasaki, Tadanori, Yoshida, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594877/
https://www.ncbi.nlm.nih.gov/pubmed/36303951
http://dx.doi.org/10.2147/OTT.S383769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594877/
https://www.ncbi.nlm.nih.gov/pubmed/36303951
http://dx.doi.org/10.2147/OTT.S383769

Ejemplares similares